Prolonged use of serotonin reuptake inhibitors (SRIs) in children and adolescents may increase the risk of developing type 2 diabetes, according to a study in JAMA Pediatrics.
Read more via Jamanetwork.com.
Δ
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
Notifications
